Analysen von Michael Leuchten
| 25.08.22 | Novartis Neutral | UBS AG | |
| 04.08.22 | Merck Neutral | UBS AG | |
| 21.07.22 | Roche Neutral | UBS AG | |
| 11.07.22 | Roche Neutral | UBS AG | |
| 24.06.22 | Novo Nordisk Neutral | UBS AG | |
| 14.06.22 | AstraZeneca Neutral | UBS AG | |
| 12.05.22 | Merck Neutral | UBS AG | |
| 21.04.22 | Sartorius vz. Neutral | UBS AG | |
|
Werbung
|
|||
| 08.04.22 | Sartorius vz. Neutral | UBS AG | |
| 04.03.22 | Merck Neutral | UBS AG | |
| 28.02.22 | Merck Neutral | UBS AG | |
| 22.02.22 | Fresenius Neutral | UBS AG | |
| 11.02.22 | Roche Neutral | UBS AG | |
| 04.02.22 | Roche Neutral | UBS AG | |
| 03.02.22 | Novo Nordisk Neutral | UBS AG | |
| 15.12.21 | Roche Neutral | UBS AG | |
| 02.12.21 | Roche Neutral | UBS AG | |
| 26.11.21 | Novo Nordisk Neutral | UBS AG | |
| 24.11.21 | Roche Neutral | UBS AG | |
| 19.11.21 | Novo Nordisk Neutral | UBS AG | |
| 09.11.21 | Roche Neutral | UBS AG | |
| 04.11.21 | Roche Neutral | UBS AG | |
| 03.11.21 | Novo Nordisk Neutral | UBS AG | |
| 02.11.21 | Fresenius Neutral | UBS AG | |
| 21.10.21 | Roche Neutral | UBS AG | |
| 20.10.21 | Roche Neutral | UBS AG | |
| 29.09.21 | Roche Neutral | UBS AG | |
| 10.09.21 | Merck Neutral | UBS AG | |
| 09.09.21 | Merck Neutral | UBS AG | |
| 07.09.21 | Roche Neutral | UBS AG | |
| 26.08.21 | Novo Nordisk Neutral | UBS AG | |
| 17.08.21 | Novo Nordisk Neutral | UBS AG | |
| 05.08.21 | Merck Neutral | UBS AG | |
| 22.07.21 | Roche Neutral | UBS AG | |
| 19.07.21 | Roche Neutral | UBS AG | |
| 28.06.21 | Novo Nordisk Neutral | UBS AG | |
| 09.06.21 | Merck Neutral | UBS AG | |
| 18.05.21 | Merck Neutral | UBS AG | |
| 12.05.21 | Merck Neutral | UBS AG | |
| 07.05.21 | Fresenius Neutral | UBS AG | |
| 06.05.21 | Fresenius Neutral | UBS AG | |
| 05.05.21 | Merck Neutral | UBS AG | |
| 15.04.21 | GSK Neutral | UBS AG | |
| 23.03.21 | Roche Neutral | UBS AG | |
| 22.03.21 | Roche Neutral | UBS AG | |
| 15.03.21 | Roche Neutral | UBS AG | |
| 08.03.21 | Roche Neutral | UBS AG | |
| 04.03.21 | Merck Neutral | UBS AG | |
| 18.02.21 | Novo Nordisk Neutral | UBS AG | |
| 18.02.21 | AstraZeneca Neutral | UBS AG | |